Home › Funds › Capricorn Fund Managers Ltd › ADPT

Capricorn Fund Managers Ltd position in ADPT

ADAPTIVE BIOTECHNOLOGIES COR · Health Care

Capricorn Fund Managers Ltd reported holding 367,000 shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR) in its Q3 2026 13F filing — a position valued at US$10.6M, representing 1.02% of its reported portfolio and ranking #39 among its reported holdings. Capricorn Fund Managers Ltd has disclosed ADPT holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)367.00K sh
Reported value held$10.61M
Portfolio Weight1.02%
First reportedQ1 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Capricorn Fund Managers Ltd's ADPT position evolved

Capricorn Fund Managers Ltd first disclosed a stake in ADPT in Q1 2026 at 1,291,773 shares (US$17.9M). Across 3 filings, Capricorn Fund Managers Ltd increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 367,000 shares valued at US$10.6M — an increase of 344,307 shares quarter over quarter.. Notable position changes include a 98% trim in Q2 2026 (shares rose 35% over the following quarter), a 1517% increase in Q3 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 1.29M $17.93M New
Q2 2026 22.69K $486.76K Reduce
Q3 2026 367.00K $10.61M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ADPT and 13F data

ADPT (ADAPTIVE BIOTECHNOLOGIES COR) is a Health Care company. 58 other funds we track also report a position in ADPT — the largest reported positions include Viking Global Investors (US$643.4M), VIKING GLOBAL INVESTORS LP (US$643.4M), Aristotle Atlantic Partners, LLC (US$39.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ADPT

All ADPT fund holders →

FAQ

How long has Capricorn Fund Managers Ltd held ADPT?

Capricorn Fund Managers Ltd has disclosed ADPT holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Capricorn Fund Managers Ltd's current position in ADPT?

As of Q3 2026, Capricorn Fund Managers Ltd holds 367.00K shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), valued at $10.61M, representing 1.02% of its reported portfolio and ranking #39.

Has Capricorn Fund Managers Ltd been buying or selling ADPT?

In the latest 13F filing (Q3 2026), Capricorn Fund Managers Ltd increased its position in ADPT.

Which other funds hold ADPT?

Other major institutional holders of ADPT include Viking Global Investors, VIKING GLOBAL INVESTORS LP, Aristotle Atlantic Partners, LLC, among 58 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.